SANOFI — Sanofi India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹139.66bn
- IN₹137.01bn
- IN₹20.13bn
- 58
- 12
- 82
- 52
Annual cashflow statement for Sanofi India, fiscal year end - December 31st, INR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,772 | 12,576 | 8,643 | 8,455 | 4,314 |
| Depreciation | |||||
| Non-Cash Items | -172 | -5,487 | -2,012 | -644 | 1,179 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,311 | -2,168 | -3,063 | -5,903 | -2,866 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6,111 | 5,588 | 3,987 | 2,304 | 3,009 |
| Capital Expenditures | -414 | -230 | -222 | -343 | -364 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3,178 | 6,538 | 6,731 | 718 | 172 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2,764 | 6,308 | 6,509 | 375 | -192 |
| Financing Cash Flow Items | -16 | -18 | -17 | -17 | -15 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8,100 | -8,490 | -15,827 | -8,783 | -3,924 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 775 | 3,406 | -5,331 | -6,104 | -1,107 |